BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 20462647)

  • 21. Incentive-compatible guaranteed renewable health insurance premiums.
    Herring B; Pauly MV
    J Health Econ; 2006 May; 25(3):395-417. PubMed ID: 16584793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Out with the old, in with the young: lifetime community rating.
    Hindle D
    Aust Health Rev; 1999; 22(1):156-60. PubMed ID: 10387898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimal risk adjustment with adverse selection and spatial competition.
    Jack W
    J Health Econ; 2006 Sep; 25(5):908-26. PubMed ID: 16712986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insurability and the HIV epidemic: ethical issues in underwriting.
    Daniels N
    Milbank Q; 1990; 68(4):497-525. PubMed ID: 2292989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk adjustment in Switzerland.
    Beck K; Spycher S; Holly A; Gardiol L
    Health Policy; 2003 Jul; 65(1):63-74. PubMed ID: 12818746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Response: The case for risk-based subsidies in public health insurance.
    Van de Ven W
    Health Econ Policy Law; 2006 Apr; 1(Pt 2):195-9; discussion 201-2. PubMed ID: 18634691
    [No Abstract]   [Full Text] [Related]  

  • 27. Introducing risk adjustment and free health plan choice in employer-based health insurance: Evidence from Germany.
    Pilny A; Wübker A; Ziebarth NR
    J Health Econ; 2017 Dec; 56():330-351. PubMed ID: 29248059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Re-insurance in the Swiss health insurance market: Fit, power, and balance.
    Schmid CP; Beck K
    Health Policy; 2016 Jul; 120(7):848-55. PubMed ID: 27157115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Economic efficiency of gate-keeping compared with fee for service plans: a Swiss example.
    Schwenkglenks M; Preiswerk G; Lehner R; Weber F; Szucs TD
    J Epidemiol Community Health; 2006 Jan; 60(1):24-30. PubMed ID: 16361451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk selection and the specification of the conventional risk adjustment formula.
    Schokkaert E; Van de Voorde C
    J Health Econ; 2004 Nov; 23(6):1237-59. PubMed ID: 15556244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prior health expenditures and risk sharing with insurers competing on quality.
    Marchand M; Sato M; Schokkaert E
    Rand J Econ; 2003; 34(4):647-69. PubMed ID: 14992229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Are Colombian sickness funds cream skimming enrollees? An analysis with suggestions for policy improvement.
    Trujillo AJ; McCalla DC
    J Policy Anal Manage; 2004 Aug; 23(4):873-88. PubMed ID: 15499708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Do insurers respond to risk adjustment? A long-term, nationwide analysis from Switzerland.
    von Wyl V; Beck K
    Eur J Health Econ; 2016 Mar; 17(2):171-83. PubMed ID: 25663430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selection Incentives for Health Insurers in the Presence of Sophisticated Risk Adjustment.
    van Kleef RC; Eijkenaar F; van Vliet RCJA
    Med Care Res Rev; 2020 Dec; 77(6):584-595. PubMed ID: 30704337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk adjustment wrinkle.
    Med Netw Strategy Rep; 1999 Jan; 8(1):1-5. PubMed ID: 10345801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk segmentation: goal or problem?
    Feldman R; Dowd B
    J Health Econ; 2000 Jul; 19(4):499-512. PubMed ID: 11010237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Managed competition: the future, not the past.
    Sipkoff M
    Manag Care; 2003 Aug; 12(8):24-7. PubMed ID: 12966847
    [No Abstract]   [Full Text] [Related]  

  • 38. The practice of risk adjustment.
    Bowen B
    Inquiry; 1995; 32(1):33-40. PubMed ID: 7713616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk adjustment and risk selection on the sickness fund insurance market in five European countries.
    van de Ven WP; Beck K; Buchner F; Chernichovsky D; Gardiol L; Holly A; Lamers LM; Schokkaert E; Shmueli A; Spycher S; Van de Voorde C; van Vliet RC; Wasem J; Zmora I
    Health Policy; 2003 Jul; 65(1):75-98. PubMed ID: 12818747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk selection in the health care market: a workshop overview.
    Gauthier AK; Lamphere JA; Barrand NL
    Inquiry; 1995; 32(1):14-22. PubMed ID: 7713613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.